AU2470801A - Tankyrase h, compositions involved in the cell cycle and methods of use - Google Patents

Tankyrase h, compositions involved in the cell cycle and methods of use Download PDF

Info

Publication number
AU2470801A
AU2470801A AU24708/01A AU2470801A AU2470801A AU 2470801 A AU2470801 A AU 2470801A AU 24708/01 A AU24708/01 A AU 24708/01A AU 2470801 A AU2470801 A AU 2470801A AU 2470801 A AU2470801 A AU 2470801A
Authority
AU
Australia
Prior art keywords
cell cycle
protein
cell
cycle protein
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24708/01A
Other languages
English (en)
Inventor
Eva Chan
Betty Huang
Ying Luo
Valeria Ossovskaya
Xiang Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of AU2470801A publication Critical patent/AU2470801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1077Pentosyltransferases (2.4.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU24708/01A 1999-10-25 2000-10-25 Tankyrase h, compositions involved in the cell cycle and methods of use Abandoned AU2470801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/427,154 US6589725B1 (en) 1999-10-25 1999-10-25 Tankyrase H, compositions involved in the cell cycle and methods of use
US09427154 1999-10-25
PCT/US2000/041528 WO2001030987A2 (en) 1999-10-25 2000-10-25 Tankyrase h, compositions involved in the cell cycle and methods of use

Publications (1)

Publication Number Publication Date
AU2470801A true AU2470801A (en) 2001-05-08

Family

ID=23693704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24708/01A Abandoned AU2470801A (en) 1999-10-25 2000-10-25 Tankyrase h, compositions involved in the cell cycle and methods of use

Country Status (6)

Country Link
US (2) US6589725B1 (enExample)
EP (1) EP1238063A2 (enExample)
JP (1) JP2003512836A (enExample)
AU (1) AU2470801A (enExample)
CA (1) CA2388332A1 (enExample)
WO (1) WO2001030987A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061813A1 (en) 1999-04-09 2000-10-19 Geron Corporation A second mammalian tankyrase
US6887675B1 (en) * 1999-10-25 2005-05-03 Rigel Pharmaceuticals, Inc. Tankyrase H, compositions involved in the cell cycle and methods of use
US20020142334A1 (en) * 2001-01-30 2002-10-03 Brown Janice A. Methods of detecting poly(ADP-ribose) polymerase enzymatic activity
US7059920B2 (en) * 2003-06-25 2006-06-13 International Connectors & Cable Corp. Spring clip connector
EP1836320A2 (en) * 2005-01-07 2007-09-26 Arqule, Inc. Compositions for modulation of parp and methods for screening for same
WO2009027650A1 (en) * 2007-08-24 2009-03-05 The Institute Of Cancer: Royal Cancer Hospital Materials and methods for exploiting synthetic lethality in brca-associated cancers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006123A1 (en) 1991-09-20 1993-04-01 Fred Hutchinson Cancer Research Center Human cyclin e
US5726025A (en) 1995-04-20 1998-03-10 President And Fellows Of Harvard College Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell cycle regulatory proteins
AU6956798A (en) 1997-04-10 1998-10-30 Genetics Institute Inc. Secreted expressed sequence tags (sests)
AUPO938897A0 (en) 1997-09-23 1997-10-16 Garvan Institute Of Medical Research A potential effector for the grb7 family of signalling proteins
US6277613B1 (en) 1998-06-10 2001-08-21 The Rockefeller University TRF1 binding protein, methods of use thereof
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
PL210415B1 (pl) 1999-01-11 2012-01-31 Agouron Pharma Pochodne indolu, środek farmaceutyczny i zastosowanie pochodnych indolu
WO2000061813A1 (en) 1999-04-09 2000-10-19 Geron Corporation A second mammalian tankyrase
WO2000072021A2 (en) 1999-05-26 2000-11-30 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
WO2000077225A1 (en) 1999-06-11 2000-12-21 Whitehead Institute For Biomedical Research A novel insulin signaling molecule
EP1192259A1 (en) 1999-06-29 2002-04-03 Icos Corporation Tankyrase2 materials and methods
US6455290B1 (en) 1999-07-09 2002-09-24 Pharmacia Italia S.P.A. Tankyrase homolog protein (THP), nucleic acids, and methods related to the same

Also Published As

Publication number Publication date
WO2001030987A3 (en) 2001-12-13
EP1238063A2 (en) 2002-09-11
US6589725B1 (en) 2003-07-08
US6617102B1 (en) 2003-09-09
JP2003512836A (ja) 2003-04-08
WO2001030987A2 (en) 2001-05-03
CA2388332A1 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
EP1261720A2 (en) Cell cycle proteins associated with rad9, compositions and methods of use
US6589725B1 (en) Tankyrase H, compositions involved in the cell cycle and methods of use
US6887675B1 (en) Tankyrase H, compositions involved in the cell cycle and methods of use
US20050074825A1 (en) Tankyrase H, compositions involved in the cell cycle and methods of use
US6709839B1 (en) SYK-UBP proteins, compositions and methods of use
US7420045B1 (en) IAPs associated cell cycle proteins, compositions and methods of use
AU770311B2 (en) PCNA associated cell cycle proteins, compositions and methods of use
US7001732B2 (en) RIP3 associated cell cycle protein
WO2001021799A9 (en) Traf4 associated cell cycle proteins, compositions and methods of use
AU7710700A (en) Novel pcna-associated cell cycle proteins, compositions and methods of use
CA2387731A1 (en) P15paf cell cycle proteins associated with pcna, compositions and methods of use
WO2002086170A1 (en) Tankyrase h, compositions involved in the cell cycle and methods of use
CA2385235A1 (en) Checkpoint gene associated cell cycle proteins, compositions and methods of use